Physician profile
Jacob B Oldham
NPI 1033109632
$2,393.50
in general payments reported to CMS, 2019-2025
10 companies · $63.70 in 2025
The $63.70 reported for 2025 was less than what a typical Orthopaedic Surgery provider received nationally (typical 2025 total: $569).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2020: $169 · 2021: $1,785 · 2022: $186 · 2023: $128 · 2024: $63.31 · 2025: $63.70.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $255.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $254.83 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Impactortho, INC. | $1,314.30 | 2021-2022 | |
| Zimmer Biomet Holdings, INC. | $359.91 | 2020-2021 | |
| Orthofix Medical, INC. | $291.60 | 2021-2025 | Physio-Stim |
| Stryker Corporation | $287.57 | 2020-2022 | |
| Bioventus LLC | $32.36 | 2021-2025 | Xcell |
| Heron Therapeutics, INC. | $30.00 | 2022 | |
| Ferring Pharmaceuticals INC. | $22.32 | 2025 | Euflexxa |
| Pacira Therapeutics, INC. | $22.19 | 2020 | |
| Depuy Synthes Sales INC. | $18.66 | 2023 | Orthovisc, Monovisc |
| Smith+Nephew, INC. | $14.59 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Jacob Oldham listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.